Insmed Inc (INSM)
70.53
-0.06
(-0.08%)
USD |
NASDAQ |
Dec 24, 16:00
Insmed Free Cash Flow: -636.03M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals Inc | 16.06M |
| Cytokinetics Inc | -407.05M |
| Amicus Therapeutics Inc | -31.51M |
| Collegium Pharmaceutical Inc | 192.43M |
| Krystal Biotech Inc | 58.06M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -180.92M |
| Cash from Investing (Quarterly) | -1.003B |
| Cash from Financing (Quarterly) | 397.20M |
| Free Cash Flow Per Share (Quarterly) | -1.063 |
| Free Cash Flow to Equity (Quarterly) | 31.84M |
| Free Cash Flow to Firm (Quarterly) | -163.45M |
| Free Cash Flow Yield | -5.80% |